ArticlePharmaceuticals (Basel, Switzerland)2023

Morroniside Inhibits Inflammatory Bone Loss through the TRAF6-Mediated NF-κB/MAPK Signalling Pathway.

Jirimutu Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.